Replimune Group Inc [NASDAQ: REPL] slipped around -2.51 points on Tuesday, while shares priced at $7.50 at the close of the session, down -25.07%.
Compared to the average trading volume of 769.40K shares, REPL reached a trading volume of 4049560 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Replimune Group Inc [REPL]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for REPL shares is $22.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on REPL stock is a recommendation set at 1.14. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Replimune Group Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 28, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on April 17, 2023, representing the official price target for Replimune Group Inc stock. Previously, the target price had yet another raise to $52, while Piper Sandler analysts kept a Overweight rating on REPL stock.
The Average True Range (ATR) for Replimune Group Inc is set at 0.77 The Price to Book ratio for the last quarter was 1.20, with the Price to Cash per share for the same quarter was set at 6.97.
How has REPL stock performed recently?
Replimune Group Inc [REPL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -20.13. With this latest performance, REPL shares gained by 0.54% in over the last four-week period, additionally sinking by -36.22% over the last 6 months – not to mention a rise of 14.33% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for REPL stock in for the last two-week period is set at 34.84, with the RSI for the last a single of trading hit 30.77, and the three-weeks RSI is set at 36.55 for Replimune Group Inc [REPL]. The present Moving Average for the last 50 days of trading for this stock 9.98, while it was recorded at 9.39 for the last single week of trading, and 11.29 for the last 200 days.
Replimune Group Inc [REPL]: Deeper insight into the fundamentals
Replimune Group Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 11.43 and a Current Ratio set at 11.43.
Earnings analysis for Replimune Group Inc [REPL]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for REPL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Replimune Group Inc go to 20.63%.
Insider trade positions for Replimune Group Inc [REPL]
The top three institutional holders of REPL stocks are: BAKER BROS. ADVISORS LP with ownership of 10.05 million shares, which is approximately 14.5193%. PRICE T ROWE ASSOCIATES INC /MD/, holding 9.24 million shares of the stock with an approximate value of $$83.13 million in REPL stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $$50.06 million in REPL stock with ownership which is approximately 8.0394%.
